Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-07
DOI
10.1186/s12885-020-06888-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BAYESIAN ANALYSIS OF BASELINE RISK OF CIN2 AND ≥CIN3 BY HPV GENOTYPE IN A EUROPEAN REFERRAL COHORT
- (2019) Jesper Bonde et al. INTERNATIONAL JOURNAL OF CANCER
- Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies
- (2019) Lan Xu et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
- (2018) Camilla Lagheden et al. BRITISH JOURNAL OF CANCER
- The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
- (2018) Mark H. Stoler et al. GYNECOLOGIC ONCOLOGY
- Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
- (2018) Lan Xu et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening
- (2018) Michela Iacobellis et al. Virology Journal
- Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
- (2018) Lan Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Validation of EUROArray HPV test using the VALGENT framework
- (2018) Jessica Viti et al. JOURNAL OF CLINICAL VIROLOGY
- Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid
- (2017) Mark D. Krevolin et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
- (2017) Helena Lamin et al. BMJ Open
- Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions
- (2016) Marc Arbyn et al. ANNALS OF INTERNAL MEDICINE
- A cohort study of cervical screening using partial HPV typing and cytology triage
- (2016) Mark Schiffman et al. INTERNATIONAL JOURNAL OF CANCER
- The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
- (2016) Ditte Ejegod et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
- (2016) Mario Poljak et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening
- (2016) A.T. Hesselink et al. JOURNAL OF CLINICAL VIROLOGY
- Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
- (2015) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
- (2015) Beatriz Serrano et al. EUROPEAN JOURNAL OF CANCER
- A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results
- (2015) Mark Schiffman et al. GYNECOLOGIC ONCOLOGY
- HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
- (2014) Jesper Bonde et al. BMC INFECTIOUS DISEASES
- Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
- (2014) Louise T. Thomsen et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial
- (2014) Vitaly Smelov et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region
- (2014) A. T. Hesselink et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical Validation of the Cervista HPV HR Test According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Cancer Screening
- (2014) A. Boers et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Are 20 human papillomavirus types causing cervical cancer?
- (2014) Marc Arbyn et al. JOURNAL OF PATHOLOGY
- Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
- (2013) Susanne K. Kjær et al. CANCER CAUSES & CONTROL
- The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
- (2013) D. A. M. Heideman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Long-Term Stability of Human Genomic and Human Papillomavirus DNA Stored in BD SurePath and Hologic PreservCyt Liquid-Based Cytology Media
- (2013) P. M. Agreda et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening
- (2013) A. T. Hesselink et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prevalence of Human Papillomavirus Infection in Unselected SurePath Samples Using the APTIMA HPV mRNA Assay
- (2013) Matejka Rebolj et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
- (2013) Sarah Preisler et al. PLoS One
- A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
- (2013) Davit Bzhalava et al. VIROLOGY
- Clinical Validation of a Type-Specific Real-Time Quantitative Human Papillomavirus PCR against the Performance of Hybrid Capture 2 for the Purpose of Cervical Cancer Screening
- (2012) C. E. Depuydt et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
- (2012) Marc Arbyn et al. VACCINE
- Formaldehyde Substitute Fixatives
- (2011) Cathy B. Moelans et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
- (2011) D. A. M. Heideman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Formaldehyde substitute fixatives: effects on nucleic acid preservation
- (2011) C. B. Moelans et al. JOURNAL OF CLINICAL PATHOLOGY
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening
- (2009) A. T. Hesselink et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
- (2009) A. Soderlund-Strand et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- (2008) Chris J.L.M. Meijer et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started